Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Tamibarotene

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Syros Announces Topline Data from SELECT-MDS-1 Trial in MDS
    Syros Announces Topline Data from SELECT-MDS-1 Trial in MDS

    12 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241112019957/en

    BUSINESSWIRE
    12 Nov 2024
    Share Share
    Rege Nephro Completes Series B Funding For Kidney Disease Trials
    Rege Nephro Completes Series B Funding For Kidney Disease Trials

    07 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rege-nephro-co-ltd-successfully-completes-series-b-funding-to-accelerate-kidney-disease-therapy-trials-302268655.html

    PR NEWSWIRE
    07 Oct 2024
    Share Share
    Syros To Host Webcast On MDS, Tamibarotene Opportunity In RARA Overexpression
    Syros To Host Webcast On MDS, Tamibarotene Opportunity In RARA Overexpression

    13 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240613264695/en

    BUSINESSWIRE
    13 Jun 2024
    Share Share
    Rege Nephro: Phase 2 Tamibarotene Trial In ADPKD Patient Enrollment
    Rege Nephro: Phase 2 Tamibarotene Trial In ADPKD Patient Enrollment

    28 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/rege-nephro-co-ltd-announces-patient-enrollment-for-phase-ii-clinical-trial-of-tamibarotene-for-adpkd-302155910.html

    PR NEWSWIRE
    28 May 2024
    Share Share
    Syros Highlights 2024 Milestones to Deliver on the Value of Tamibarotene
    Syros Highlights 2024 Milestones to Deliver on the Value of Tamibarotene

    08 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240108581653/en

    BUSINESSWIRE
    08 Jan 2024
    Share Share
    Syros’ stock up after sharing early, mid-stage AML data
    Syros’ stock up after sharing early, mid-stage AML data

    07 Dec 2023

    // Gabrielle Masson FIERCE BIOTECH

    https://ftp.tmfsummit.com/biotech/syros-stock-after-sharing-early-mid-stage-aml-data

    Gabrielle Masson FIERCE BIOTECH
    07 Dec 2023
    Share Share